Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$43.51M+32.4%-$60.61M+6.3%-$66.28M+5.6%-$65.89M+7.9%-$64.36M+11.8%
$6.78M+2.9%$6.94M+10.5%$7.02M+14.0%$6.87M+9.3%$6.58M+8.0%
$4.78M-43.9%$4.55M-59.2%$4.52M-67.6%$5.89M-63.7%$8.52M-49.7%
-$23.82M+32.8%-$11.19M+74.4%-$16.65M+54.7%
$3.91M$3.2M$3.9M
-$3.91M-114%-$3.07M-106%-$2.01M-103%$8.99M-84.2%$28.38M-55.4%
$20M
$16.27M+323%$11.56M+431%$7.66M+250%-$3.18M+43.4%-$7.29M-20.0%
-$19.74M-199%-$6.13M-169%$3.68M-83.4%
-$27.9M-$29.96M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does The Oncology Institute, Inc. generate?
The Oncology Institute, Inc. (TOI) generated -$30.0M in operating cash flow over the trailing twelve months.
What is The Oncology Institute, Inc.'s free cash flow?
After $3.9M of capital expenditures, The Oncology Institute, Inc.'s free cash flow was -$27.9M over the trailing twelve months, up 36.7% year over year.
Where does The Oncology Institute, Inc.'s cash flow data come from?
Every line is extracted from The Oncology Institute, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.